Planned intervention: On Wednesday April 3rd 05:30 UTC Zenodo will be unavailable for up to 2-10 minutes to perform a storage cluster upgrade.
Published January 21, 2021 | Version v1
Journal article Open

FORMULATION AND CHARACTERIZATION OF GLICLAZIDE LOADED ANOGEL FOR TREATMENT OF DIABETES MELLITUS TYPE-2

Description

Gliclazide is a weak acid compound with high lipophilicity and has pH-dependent solubility. The drug is insoluble under acidic condition in the stomach, when consumed orally causes several side effects namely heartburn, anorexia, nausea and ulcer This leads to reduced patient compliance and in turn reduces drug efficacy. Topical drug delivery are potential routes for a variety of drugs with limited oral bioavailability. Nanogel formulations are efficient in enhancing the delivery of such drugs. Incorporating drug in the form of nanogel has potential in enhancing the poorly permeable drug for topical drug delivery. It showed promising results on delivering also showed a superiority based on its retention and adhesive properties for better absorption. In the report, a nanogel was developed and evaluated as a platform for topical drug delivery. We have prepared gliclazide nanogel at different drug polymer ratios. The particle size polydispersity retention viscosity were evaluated F2 and F4 showed higher releasing rate compared to F1 On the other hand, F1 showed higher skin permeation. Gliclazide nanogel formulation with ethanol as a penetration enhancer demonstrated a pronounced effect on enhancing Gliclazide skin permeability and content upon topical application. Based on these results, this study is further directed to choose a model for diabetes mellitus type 2 as a therapeutic tool.

Keywords: Nanogel, Nanotechnology, Gliclazide, topical drug delivery

Files

428.Pragati trivedi -PRAGATI RA.pdf

Files (1.0 MB)

Name Size Download all
md5:7acffd8075b2cede2c377ac89867ef6c
1.0 MB Preview Download